Concepedia

G. Smith

GS

Statistics

Publications

70

Citations

2.5K

H-Index

29

Active since

1953

Affiliations

AstraZeneca (United Kingdom)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

AstraZeneca (United States)

University of Manchester

AstraZeneca (Poland)

G. Smith is an author at AstraZeneca (United Kingdom) specializing in medicinal chemistry, chemistry, and pharmacy.

ORCID

Publications per year

1953–2024

70

Publications

70

Targeting Xist with compounds that disrupt RNA structure and X inactivation

Rodrigo Aguilar, Kerrie B. Spencer, Barry Kesner et al. · Nature · 2022 · 129 citations · Full text

, , +10

The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals

Joerg Schlingemann, Michael J. Burns, David J. Ponting et al. · Journal of Pharmaceutical Sciences · 2022 · 127 citations · Full text

, , +13

Designing Drugs to Avoid Toxicity

G. Smith · Progress in medicinal chemistry · 2011 · 116 citations

, , +12

Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space

Noreen F. Rizvi, John P. Santa Maria, Ali Nahvi et al. · SLAS DISCOVERY · 2019 · 112 citations · Full text

, , +17

Indoles. Part I. The formylation of indole and some reactions of 3-formylindole

G. Smith · Journal of the Chemical Society (Resumed) · 1954 · 110 citations

, , +5

1–5 of 70